Welcome to KG Jebsen center for Diabetes research
Our aim is to uncover novel disease mechanisms in diabetes development and to establish tools for differentiating specific subgroups of patients, thus facilitating individualized care.
The head of the group is Professor Pål R. Njølstad, MD PhD. and contains 6 nodes leaded by Co-Principal investigators: Professor Anders Molven, PhD; Professor Gunnar Mellgren, MD PhD; Professor Ottar Nygård, MD PhD; Professor Rolv Terje Lie, PhD; Professor Helge Ræder MD PhD.
The main objectives of the group are:
1) find new genetic risk factors for diabetes and its complications
2) reveal novel disease mechanisms in diabetes development
3) develop and implement improved targeted treatment of diabetes.
KG Jebsen Center for Diabetes Research is a collaboration on diabetes reseach between the University of Bergen, Haukeland University hospital. We are located at the Children and Youth Hospital building, 6th floor, Block 2, Haukelandsbakken 15N-5021 Bergen, NORWAY.
External Collaborators
Professor C. Ronald Kahn MD, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA
Professor Tiinamaija Tuomi MD PhD, University of Helsinki, Helsinki, Finland
Consultant physician Torild Skrivarhaug MD PhD, Oslo University Hospital, Oslo, Norway
Ass. Professor Daniel Macarthur PhD, Massachussets General Hospital, Boston, MA, USA
Professor Leif Groop MD PhD, Researcher Ola Hansson, Lund University, Malmø, Sweden
Professor Mark I. McCarthy MD PhD, Professor Anna L. Gloyn PhD, Oxford University, Oxford, UK
Professor Andrew Hattersley MD PhD, Professor Sian Ellard PhD, University of Exeter, Exeter, UK
Ass. Professor Jose Florez MD PhD, Researcher Jason Flannick PhD, Broad Institute of Harvard and MIT, Cambridge, MA, USA
Professor Camilla Stoltenberg MD PhD, Researcher Lars Christian Stene PhD, Researcher Gun Peggy Knutsen PhD, Norwegian Institute of Public Health, Oslo, Norway
Available PhD and Postdoc positions at the center. Job advertisement to be released in week 11.
We Thank the KG Jebsen Foundation for supporting important diabetes research in Bergen. We also thank UoB, Helse Vest, RCN, BFS, Novo Nordisk and ERC (EU).
